Clinical Trial

A Study to Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the pharmacokinetics (PK), safety and tolerability of different oral formulations of AZD5004, and to evaluate the effect of food on these formulations in healthy participants.
Protocol Amendment History 2 changes
critical Trial completed 2026-06-11
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-23
Trial Details
NCT Number NCT07455825
Lead Sponsor AstraZeneca
Collaborators: Parexel
Conditions Healthy Participants
Enrollment 65 participants
Start Date 2026-03-05
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-10